Search

everythinglearnresearchcommunity

for

Search:↓

PRP and ADM-STSG co-grafts improve healing and reduce complications in hidradenitis suppurativa surgery.

Standardized PRP is effective for tendinopathies, with most patients improving after one injection.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Follicular Unit Extraction (FUE) hair transplant is less invasive, leaves no scars, and has quicker recovery times, but it's more time-consuming and challenging. Automation helps speed up the process and improve graft survival, reducing the need for traditional strip surgery.

Stem cell technology may improve hair loss treatments by providing more effective and personalized options.

Gray short-tailed opossums' skin shifts from helping with breathing to regulating body temperature as they grow.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Individualized treatment and support can help most couples with recurrent implantation failure achieve pregnancy.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

Platelet-rich plasma therapy improves oral lichen planus symptoms with few side effects.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

A holistic approach combining medical, surgical, and psychological therapies is essential for effectively managing diabetes.

Stem cells from elderly skin can become neurons, offering potential for brain therapy.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

Genetic differences affect how people respond to COVID-19.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

More research is needed to understand how adipose-derived stem cells affect liver cancer treatment.

Origanum vulgare leaf extract reduces liver and kidney damage caused by finasteride in mice.